Business Arcutis Biotherapeutics Achieves Profitability with Record Revenue Surge Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) celebrated a remarkable financial turnaround, achieving profitability in the third quarter of 2023. The company’s revenues more than doubled, soaring... Editorial29 October, 2025